Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced in August.
Recently formed regenerative therapies firm Ambys Medicines launched with a $60m Series A round provided by Third Rock Ventures...








